Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian I Carr

Showing results (81-90 of 187) with videos related to

Pageof 19
Sort By:
Radiology|January 5, 2002
Hepatocellular carcinoma in noncirrhotic liver: CT, clinical, and pathologic findings in 39 U.S. residentsGiuseppe Brancatelli, Michael P Federle, Luigi Grazioli, et al.
Seminars in Oncology|August 1, 2012
Developments in liver transplantation for hepatocellular carcinomaEmmanuel Melloul, Mickael Lesurtel, Brian I Carr, et al.
Biochemical Pharmacology|August 26, 2006
Fluorinated Cpd 5, a pure arylating K-vitamin derivative, inhibits human hepatoma cell growth by inhibiting Cdc25 and activating MAPKSiddhartha Kar, Meifang Wang, Seung Wook Ham, et al.
Medical Oncology (Northwood, London, England)|January 26, 2011
Cell membrane and cytoplasmic epidermal growth factor receptor expression in pancreatic ductal adenocarcinomaAmit Mahipal, Mary J Mcdonald, Agnieszka Witkiewicz, et al.
Digestive Diseases and Sciences|April 6, 2011
Small HCCs identified by screeningPetr Pancoska, Massimo De Giorgio, Stefano Fagiuoli, et al.
The Journal of Biological Chemistry|March 26, 2002
Identification of epidermal growth factor receptor as a target of Cdc25A protein phosphataseZiqiu Wang, Meifang Wang, John S Lazo, et al.
Carcinogenesis|March 29, 2003
Antitumor and anticarcinogenic actions of Cpd 5: a new class of protein phosphatase inhibitorSiddhartha Kar, Meifang Wang, Craig S Wilcox, et al.
Bioorganic & Medicinal Chemistry Letters|March 24, 2007
Fluorinated NSC as a Cdc25 inhibitorHwangseo Park, Brian I Carr, Minghua Li, et al.
Cancer Biology & Therapy|September 14, 2006
H32, a non-quinone sulfone analog of vitamin K3, inhibits human hepatoma cell growth by inhibiting Cdc25 and activating ERKSiddhartha Kar, Meifang Wang, Seung Wook Ham, et al.
Expert Opinion on Pharmacotherapy|October 20, 2015
Modulation of sensitivity and resistance to multikinase inhibitors by microenvironmental platelet factors in HCCRosalba D'Alessandro, Caterina Messa, Maria Grazia Refolo, et al.
Pageof 19

Showing results (81-90 of 187) with videos related to

Sort By:
Pageof 19
Radiology|January 5, 2002
Hepatocellular carcinoma in noncirrhotic liver: CT, clinical, and pathologic findings in 39 U.S. residentsGiuseppe Brancatelli, Michael P Federle, Luigi Grazioli, et al.
Seminars in Oncology|August 1, 2012
Developments in liver transplantation for hepatocellular carcinomaEmmanuel Melloul, Mickael Lesurtel, Brian I Carr, et al.
Biochemical Pharmacology|August 26, 2006
Fluorinated Cpd 5, a pure arylating K-vitamin derivative, inhibits human hepatoma cell growth by inhibiting Cdc25 and activating MAPKSiddhartha Kar, Meifang Wang, Seung Wook Ham, et al.
Medical Oncology (Northwood, London, England)|January 26, 2011
Cell membrane and cytoplasmic epidermal growth factor receptor expression in pancreatic ductal adenocarcinomaAmit Mahipal, Mary J Mcdonald, Agnieszka Witkiewicz, et al.
Digestive Diseases and Sciences|April 6, 2011
Small HCCs identified by screeningPetr Pancoska, Massimo De Giorgio, Stefano Fagiuoli, et al.
The Journal of Biological Chemistry|March 26, 2002
Identification of epidermal growth factor receptor as a target of Cdc25A protein phosphataseZiqiu Wang, Meifang Wang, John S Lazo, et al.
Carcinogenesis|March 29, 2003
Antitumor and anticarcinogenic actions of Cpd 5: a new class of protein phosphatase inhibitorSiddhartha Kar, Meifang Wang, Craig S Wilcox, et al.
Bioorganic & Medicinal Chemistry Letters|March 24, 2007
Fluorinated NSC as a Cdc25 inhibitorHwangseo Park, Brian I Carr, Minghua Li, et al.
Cancer Biology & Therapy|September 14, 2006
H32, a non-quinone sulfone analog of vitamin K3, inhibits human hepatoma cell growth by inhibiting Cdc25 and activating ERKSiddhartha Kar, Meifang Wang, Seung Wook Ham, et al.
Expert Opinion on Pharmacotherapy|October 20, 2015
Modulation of sensitivity and resistance to multikinase inhibitors by microenvironmental platelet factors in HCCRosalba D'Alessandro, Caterina Messa, Maria Grazia Refolo, et al.
Pageof 19